Citius Pharmaceuticals Inc.
CTXR | NASDAQ
$0.58
-$0.02 (-3.33%)
At close: Sep 21, 2026, 4:00 PM ET
$0.58
$0 (-0.60%)
Pre-market:
Sep 22, 2026, 8:00 AM ET
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 214.25K | 209.61K | 194.32K | 179.68K | 164.87K | 152.36K |
Gross Profit | -214.25K | -209.61K | -194.32K | -179.68K | -164.87K | -152.36K |
Operating Income | -38.53M | -42M | -36.73M | -33.32M | -23.53M | -17.71M |
Interest Income | 110.08K | 758K | 1.18M | 251.4K | 261.83K | 68.07K |
Pretax Income | -38.68M | -38.85M | -31.97M | -33.06M | -23.05M | -17.55M |
Net Income | -37.43M | -39.14M | -32.54M | -33.64M | -23.13M | -17.55M |
Selling & General & Admin | 18.53M | 18.25M | 21.91M | 15.66M | 11.29M | 8.9M |
Research & Development | 9.16M | 11.91M | 14.82M | 17.66M | 12.24M | 8.81M |
Other Expenses | 10.62M | 11.84M | n/a | n/a | n/a | n/a |
Operating Expenses | 38.31M | 42M | 36.73M | 33.32M | 23.53M | 17.71M |
Interest Expense | 267.78K | n/a | n/a | 251.4K | 10.84K | 15.67K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 38.53M | 42M | 36.73M | 33.32M | 23.53M | 17.71M |
Income Tax Expense | 1.06M | 576K | 576K | 576K | n/a | n/a |
Shares Outstanding (Basic) | 11.07M | 11.59M | 9.74M | 9.74M | 7.24M | 2.61M |
Shares Outstanding (Diluted) | 11.07M | 11.59M | 10.09M | 9.74M | 7.24M | 2.61M |
EPS (Basic) | -3.38 | -5.97 | -5.57 | -5.76 | -5.64 | -0.45 |
EPS (Diluted) | -3.38 | -5.97 | -5.57 | -5.76 | -5.64 | -0.45 |
EBITDA | -38.2M | -38.64M | -31.77M | -32.88M | -22.88M | -17.38M |
EBIT | -38.42M | -38.85M | -31.97M | -33.06M | -23.04M | -17.53M |
Depreciation & Amortization | 214.25K | 209.61K | 194.32K | 179.68K | 164.87K | 152.36K |
Add to Watchlist
Select watchlists to add or remove CTXR